Literature DB >> 32435395

New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII.

Rita Meleddu1, Simona Distinto1, Filippo Cottiglia1, Rossella Angius2, Pierluigi Caboni1, Andrea Angeli3, Claudia Melis1, Serenella Deplano1, Stefano Alcaro4, Francesco Ortuso4, Claudiu T Supuran3, Elias Maccioni1.   

Abstract

In the present study we investigated the structure-activity relationships of a new series of 4-[(3-ethyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides (EMAC10101a-m). All synthesized compounds, with the exception of compound EMAC10101k, preferentially inhibit off-target hCA II isoform. Within the series, compound EMAC10101d, bearing a 2,4-dichorophenyl substituent in position 4 of the dihydrothiazole ring, was the most potent and selective toward hCA II with an inhibitory activity in the low nanomolar range.
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32435395      PMCID: PMC7236253          DOI: 10.1021/acsmedchemlett.9b00644

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

1.  Atomic resolution studies of carbonic anhydrase II.

Authors:  Craig A Behnke; Isolde Le Trong; Jeff W Godden; Ethan A Merritt; David C Teller; Jürgen Bajorath; Ronald E Stenkamp
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-04-21

Review 2.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

Review 3.  Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).

Authors:  Fabrizio Carta; Claudiu T Supuran
Journal:  Expert Opin Ther Pat       Date:  2013-03-14       Impact factor: 6.674

Review 4.  Structure and function of carbonic anhydrases.

Authors:  Claudiu T Supuran
Journal:  Biochem J       Date:  2016-07-15       Impact factor: 3.857

5.  Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates.

Authors:  Alessio Innocenti; Daniela Vullo; Andrea Scozzafava; Joseph R Casey; Claudiut Supuran
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

6.  Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents.

Authors:  Ahmed M Alafeefy; Rehan Ahmad; Maha Abdulla; Wagdy M Eldehna; Abdul-Malek S Al-Tamimi; Hatem A Abdel-Aziz; Omar Al-Obaid; Fabrizio Carta; Abdulla A Al-Kahtani; Claudiu T Supuran
Journal:  Eur J Med Chem       Date:  2016-01-06       Impact factor: 6.514

Review 7.  Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?

Authors:  Giuseppina De Simone; Anna Di Fiore; Claudiu T Supuran
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII.

Authors:  Hany S Ibrahim; Sahar M Abou-Seri; Muhammet Tanc; Mahmoud M Elaasser; Hatem A Abdel-Aziz; Claudiu T Supuran
Journal:  Eur J Med Chem       Date:  2015-09-16       Impact factor: 6.514

9.  Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.

Authors:  Rita Meleddu; Simona Distinto; Filippo Cottiglia; Rossella Angius; Marco Gaspari; Domenico Taverna; Claudia Melis; Andrea Angeli; Giulia Bianco; Serenella Deplano; Benedetta Fois; Sonia Del Prete; Clemente Capasso; Stefano Alcaro; Francesco Ortuso; Matilde Yanez; Claudiu T Supuran; Elias Maccioni
Journal:  ACS Med Chem Lett       Date:  2018-09-17       Impact factor: 4.345

10.  Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases.

Authors:  Simona Distinto; Rita Meleddu; Francesco Ortuso; Filippo Cottiglia; Serenella Deplano; Lisa Sequeira; Claudia Melis; Benedetta Fois; Andrea Angeli; Clemente Capasso; Rossella Angius; Stefano Alcaro; Claudiu T Supuran; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.